Robert S. Brody

595 total citations
11 papers, 453 citations indexed

About

Robert S. Brody is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert S. Brody has authored 11 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert S. Brody's work include Influenza Virus Research Studies (3 papers), Respiratory viral infections research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Robert S. Brody is often cited by papers focused on Influenza Virus Research Studies (3 papers), Respiratory viral infections research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Robert S. Brody collaborates with scholars based in United States, United Kingdom and Sweden. Robert S. Brody's co-authors include Marc Ballas, Anita Midha, Mohd Kashif Siddiqui, Jill Walker, Craig Barker, Yiduo Zhang, Alison Reid, David Schottenfeld, E. Brannon Morris and Irwin Katzka and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer.

In The Last Decade

Robert S. Brody

10 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert S. Brody United States 6 269 176 100 92 82 11 453
Maria-Pilar Barretina-Ginesta Spain 10 243 0.9× 65 0.4× 84 0.8× 37 0.4× 54 0.7× 35 511
Piotr Skotnicki Poland 12 135 0.5× 97 0.6× 108 1.1× 44 0.5× 50 0.6× 31 392
Emanuele Dainese Italy 10 157 0.6× 111 0.6× 59 0.6× 74 0.8× 37 0.5× 26 378
Joanna Huszno Poland 11 193 0.7× 146 0.8× 32 0.3× 40 0.4× 79 1.0× 37 425
Ying‐Hsia Chu United States 14 119 0.4× 75 0.4× 73 0.7× 58 0.6× 70 0.9× 26 492
Takaharu Kato Japan 14 304 1.1× 184 1.0× 114 1.1× 65 0.7× 22 0.3× 61 551
Cyril Abdeddaim France 10 302 1.1× 92 0.5× 131 1.3× 27 0.3× 26 0.3× 30 519
J.T. Soper United States 9 165 0.6× 112 0.6× 31 0.3× 83 0.9× 46 0.6× 14 417
Paloma Martín-Martorell Spain 11 279 1.0× 190 1.1× 37 0.4× 23 0.3× 26 0.3× 30 426
Farid El Hajbi France 10 257 1.0× 147 0.8× 39 0.4× 121 1.3× 72 0.9× 41 430

Countries citing papers authored by Robert S. Brody

Since Specialization
Citations

This map shows the geographic impact of Robert S. Brody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Brody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Brody more than expected).

Fields of papers citing papers by Robert S. Brody

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Brody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Brody. The network helps show where Robert S. Brody may publish in the future.

Co-authorship network of co-authors of Robert S. Brody

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Brody. A scholar is included among the top collaborators of Robert S. Brody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Brody. Robert S. Brody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Schabath, Matthew B., Tapashi Dalvi, Hongyue Dai, et al.. (2019). <p>A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer</p>. Cancer Management and Research. Volume 11. 9469–9481. 1 indexed citations
2.
Schabath, Matthew B., Tapashi Dalvi, Hongyue Dai, et al.. (2017). P1.01-042 Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S475–S476. 1 indexed citations
3.
4.
Brody, Robert S., Charles Liss, Heather Wray, et al.. (2017). Results from a drug utilization study of extended release quetiapine fumarate prescribed by psychiatrists as treatment for major depressive disorder in selected countries in the European Union. International Clinical Psychopharmacology. 33(2). 59–65. 1 indexed citations
5.
Więcek, Witold, Richard Lawson, Betina T. Blak, et al.. (2017). Impact of increased influenza vaccination in 2–3-year-old children on disease burden within the general population: A Bayesian model-based approach. PLoS ONE. 12(12). e0186739–e0186739. 7 indexed citations
6.
Brody, Robert S., Yiduo Zhang, Marc Ballas, et al.. (2017). PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review. Lung Cancer. 112. 200–215. 234 indexed citations
7.
Więcek, Witold, Richard Lawson, Betina T. Blak, et al.. (2017). A retrospective observational analysis of post-pandemic influenza-related outcomes in the United Kingdom, 2010–2014. Human Vaccines & Immunotherapeutics. 14(2). 368–377.
8.
Brody, Robert S., Charles Liss, Heather Wray, et al.. (2015). Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine. International Clinical Psychopharmacology. 31(1). 34–41. 9 indexed citations
9.
10.
Katzka, Irwin, Robert S. Brody, E. Brannon Morris, & Seymour Katz. (1983). Assessment of Colorectal Cancer Risk in Patients With Ulcerative Colitis: Experience From a Private Practice. Gastroenterology. 85(1). 22–29. 108 indexed citations
11.
Brody, Robert S., David Schottenfeld, & Alison Reid. (1977). Multiple primary cancer risk after therapy for Hodgkin's disease. Cancer. 40(S4). 1917–1926. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria-Pilar Barretina-Ginesta Breakdown of academic impact, for papers by Piotr Skotnicki Breakdown of academic impact, for papers by Emanuele Dainese Breakdown of academic impact, for papers by Joanna Huszno Breakdown of academic impact, for papers by Ying‐Hsia Chu Breakdown of academic impact, for papers by Takaharu Kato Breakdown of academic impact, for papers by Cyril Abdeddaim Breakdown of academic impact, for papers by J.T. Soper Breakdown of academic impact, for papers by Paloma Martín-Martorell Breakdown of academic impact, for papers by Farid El Hajbi
Rankless by CCL
2026